Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
CD177-mediated nanoparticle targeting of human and mouse neutrophils
CD177(+) neutrophils suppress epithelial cell tumourigenesis in colitis-associated cancer and predict good prognosis in colorectal cancer
CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells
CD18 deficiency evolving to megakaryocytic (M7) acute myeloid leukemia: Case report
CD180 Overexpression in Follicular Lymphoma Is Restricted to the Lymph Node Compartment
CD18 expression in granulocytes infiltrating the vitreous fluid in patients with diabetic retinopathy
CD18 is required for optimal lymphopenia-induced proliferation of mouse T cells
CD18 deficiency improves liver injury in the MCD model of steatohepatitis
CD18-mediated adhesion is required for the induction of a proinflammatory phenotype in lung epithelial cells by mononuclear cell-derived extracellular vesicles
CD180 Ligation Inhibits TLR7- and TLR9-Mediated Activation of Macrophages and Dendritic Cells Through the Lyn-SHP-1/2 Axis in Murine Lupus.
CD19-positive acute myeloblastic leukemia with trisomy 21 as a sole acquired karyotypic abnormality
CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand
CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
CD19~+CD24~(hi)CD38~(hi) B细胞亚群在系统性红斑狼疮患者外周血中的表达
CD19 as a molecular target in CNS autoimmunity
CD19 differentially regulates BCR signalling through the recruitment of PI3K
CD19 CAR-Targeted T Cells Induce Long-Term Remission and B Cell Aplasia in an Immunocompetent Mouse Model of B Cell Acute Lymphoblastic Leukemia
CD19CAR T Cells From Humble Beginnings to Cancer Immunotherapy's Poster Child
CD19-antigen specific nanoscale liposomal formulation of a SYK P-site inhibitor causes apoptotic destruction of human B-precursor leukemia cells
CD19 as a therapeutic target in a spontaneous autoimmune polyneuropathy
CD19(+)CD24(hi)CD38(hi) B Cells Maintain Regulatory T Cells While Limiting T(H)1 and T(H)17 Differentiation
CD19(+) B Cells Confer Protection against Experimental Cerebral Malaria in Semi-Immune Rodent Model
CD19+CD23+B cells, CD4+CD25+T cells, E-selectin and interleukin-12 levels in children with steroid sensitive nephrotic syndrome
CD19 Expression in B Cells Regulates Atopic Dermatitis in a Mouse Model
CD19 and CD20 Targeted Vectors Induce Minimal Activation of Resting B Lymphocytes
CD19 target-engineered T-cells accumulate at tumor lesions in human B-cell lymphoma xenograft mouse models
CD19-CAR Trials
CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome
CD19与B细胞恶性肿瘤的免疫治疗
CD19 controls Toll-like receptor 9 responses in human B cells
CD19(+)CD24(hi)CD38(hi)Bregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer
CD192 gene variant and susceptibility to cervical cancer: a meta analysis
CD19~+、CD3~+、CD4~+、CD8~+细胞对儿童重症手足口病的预警作用
CD19 and BAFF-R can signal to promote B-cell survival in the absence of Syk
CD19-Chimeric Antigen Receptor T Cells for Treatment of Chronic Lymphocytic Leukaemia and Acute Lymphoblastic Leukaemia
CD19-negative B-lymphoblastic leukemia associated with hypercalcemia, lytic bone lesions and aleukemic presentation
CD19-Targeted CAR T Cells: A New Tool in the Fight against B Cell Malignancies
CD19(+)CD24(hi)CD38(hi) B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody
CD19(+)CD20(-)CD27(hi) IL-s10-producing B cells are overrepresented in R-CHOP-treated DLBCL patients in complete remission
CD19 LYMPHOCYTE PROLIFERATION INDUCED BY Bifidobacterium animalis subsp lactis IN C57BL/6 MICE EXPERIMENTALLY INFECTED WITH Toxoplasma gondii
CD19 CAR-T cells of defined CD4(+): CD8(+) composition in adult B cell ALL patients
CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity
CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies
CD19(+)CD5(+) Cells as Indicators of Preeclampsia
CD19: a promising B cell target for rheumatoid arthritis
CD19-independent instruction of murine marginal zone B-cell development by constitutive Notch2 signaling
CD19(+)CD5(+) B Cells and B1-Like Cells Following Allogeneic Hematopoietic Stem Cell Transplantation
CD19 expression in acute leukemia is not restricted to the cytogenetically aberrant populations
CD19(+)CD21(low) B Cells and CD4(+)CD45RA(+)CD31(+) T Cells Correlate with First Diagnosis of Chronic Graft-versus-Host Disease
CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis
CD19 function in early and late B cell development: I. Maintenance of follicular and marginal zone B cells requires CD19-dependent survival signals
CD19-CD21 complex regulates an intrinsic Src family kinase amplification loop that links innate immunity with B-lymphocyte intracellular calcium responses
CD19 amplification of B lymphocyte Ca2+ responses - A role for Lyn sequestration in extinguishing negative regulation
CD19 regulates B cell maturation, proliferation, and positive selection in the FDC zone of murine splenic germinal centers
CD19 function in central and peripheral B-cell development
CD19 function in early and late B cell development. II. CD19 facilitates the pro-B/pre-B transition
CD19 chimeric antigen receptor T cell therapy for haematological malignancies
CD19 MAPS TO A REGION OF CONSERVATION BETWEEN HUMAN CHROMOSOME-16 AND MOUSE CHROMOSOME-7
CD19 and CD32b Differentially Regulate Human B Cell Responsiveness
CD19, a Response Regulator of B Lymphocytes, Regulates Wound Healing through Hyaluronan-Induced TLR4 Signaling
CD19(-)CD45(low/-)CD38(high)/CD138(+) plasma cells enrich for human tumorigenic myeloma cells
CD19 mRNA quantification improves ritwdmab treatment-to-target approach: A proof of concept study
CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis
CD19, from bench to bedside
CD19 Chimeric Antigen Receptor T Cell Therapy for the Treatment of B Cell Lineage Acute Lymphoblastic Leukemia
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
CD19-CAR-T和CD19-CAR-CIK细胞对表达CD19+K562细胞株杀伤作用的比较
CD19-CAR-T细胞治疗难治复发急性淋巴细胞白血病的研究进展
CD19~+CD24~(hi)CD38~(hi) Breg细胞在胰腺癌患者外周血中的频率及其与Treg细胞间的关系
CD19-CAR-T细胞治疗技术的产业化前景
CD19(+)CD24(hi)CD38(hi) regulatory B cells are associated with insulin resistance in type I Hashimoto's thyroiditis in Chinese females
CD19(lo)CD27(hi) Plasmablasts Suppress Harmful Th17 Inflammation Through Interleukin 10 Pathway in Colorectal Cancer
CD19xCD3 DART protein mediates human B-cell depletion in vivo in humanized BLT mice
CD19+Tim-1+B cells are decreased and negatively correlated with disease severity in Myasthenia Gravis patients
CD19: Lowering the Threshold for Antigen Receptor Stimulation of B Lymphocytes (Reprinted from Science, vol 256, pg 105-107, 1992)
CD19-specific triplebody SPM-1 engages NK and gd T cells for rapid and efficient lysis of malignant B-lymphoid cells
CD19 chimeric antigen receptor (CD19 CAR)-redirected adoptive T-cell immunotherapy for the treatment of relapsed or refractory B-cell Non-Hodgkin%26apos;s Lymphomas
CD19+B cell subsets in the peripheral blood and skin lesions of psoriasis patients and their correlations with disease severity
CD19 Is a Useful B Cell Marker After Treatment With Rituximab: Comment on the Article by Jones et al
CD19-targeted immunotherapies for treatment of patients with non-Hodgkin B-cell lymphomas
CD19 Chimeric Antigen Receptor T Cells From Patients With Chronic Lymphocytic Leukemia Display an Elevated IFN- Production Profile
CD19-specific chimeric antigen receptor-modified (CAR)-T cell therapy for the treatment of chronic lymphocytic leukemia in the ibrutinib era
CD19(+) B-Cells, a New Biomarker of Mortality in Hemodialysis Patients
CD19 targeted CAR-T therapy versus chemotherapy in re-induction treatment of refractory/relapsed acute lymphoblastic leukemia: results of a case-controlled study